Article info

PDF
Original article
Indication for CDKN2A-mutation analysis in familial pancreatic cancer families without melanomas
  1. Correspondence to Dr Femme Harinck, Erasmus MC-University Medical Center Rotterdam, Department of Gastroenterology & Hepatology, 's Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands; f.harinck{at}erasmusmc.nl
View Full Text

Citation

Harinck F, Kluijt I, van der Stoep N, et al
Indication for CDKN2A-mutation analysis in familial pancreatic cancer families without melanomas

Publication history

  • Received October 12, 2011
  • Revised March 11, 2012
  • Accepted March 16, 2012
  • First published May 25, 2012.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.